Currently, this problem is already mostly addressed by animal trials. Granted that that the pharmacokinetics of a given drug in mice, or even monkeys, won't be identical to that in humans, it's more predictive than using isolated tissue or cell preparations.
>It would just require the raw data from a variety of pharmacokinetic trials...
By and large, such trials are likely poorly relevant to the pharmacokinetics of your drug candidate, unless its very similar to an existing drug. And even then, you will still have to test your actual drug in actual people during Phase 0 trials.
>It would just require the raw data from a variety of pharmacokinetic trials...
By and large, such trials are likely poorly relevant to the pharmacokinetics of your drug candidate, unless its very similar to an existing drug. And even then, you will still have to test your actual drug in actual people during Phase 0 trials.